Dan Brennan
Stock Analyst at TD Cowen
(4.01)
# 539
Out of 5,157 analysts
133
Total ratings
49.02%
Success rate
12.72%
Average return
Main Sectors:
Stocks Rated by Dan Brennan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| A Agilent Technologies | Maintains: Buy | $170 → $157 | $116.64 | +34.60% | 14 | Feb 26, 2026 | |
| XGN Exagen | Maintains: Buy | $13 → $10 | $3.38 | +195.86% | 1 | Feb 24, 2026 | |
| GH Guardant Health | Maintains: Buy | $130 → $135 | $91.20 | +48.03% | 4 | Feb 20, 2026 | |
| BRKR Bruker | Maintains: Hold | $53 → $43 | $37.20 | +15.59% | 4 | Feb 13, 2026 | |
| TXG 10x Genomics | Maintains: Hold | $18 → $19 | $20.91 | -9.13% | 6 | Feb 13, 2026 | |
| RVTY Revvity | Maintains: Buy | $120 → $124 | $92.11 | +34.62% | 4 | Feb 3, 2026 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $696 → $683 | $509.97 | +33.93% | 15 | Jan 30, 2026 | |
| ILMN Illumina | Maintains: Hold | $115 → $140 | $124.28 | +12.65% | 14 | Jan 7, 2026 | |
| DHR Danaher | Maintains: Buy | $260 → $270 | $198.80 | +35.81% | 7 | Jan 7, 2026 | |
| AVTR Avantor | Maintains: Hold | $14 → $12 | $8.15 | +47.24% | 4 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $7 | $3.38 | +107.10% | 2 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $345 → $390 | $305.67 | +27.59% | 4 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $74 → $90 | $103.71 | -13.22% | 7 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $8 → $9 | $4.81 | +87.11% | 2 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $12 | $8.92 | +34.53% | 7 | Sep 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $15 | $14.95 | +0.33% | 1 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $19.00 | +68.42% | 1 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $110 | $94.51 | +16.39% | 4 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $8 → $2.5 | $3.63 | -31.13% | 4 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $74 | $52.32 | +41.44% | 2 | Feb 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $155 → $175 | $205.22 | -14.73% | 4 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $240 → $250 | $176.99 | +41.25% | 5 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $48 → $51 | $50.45 | +1.09% | 2 | Jul 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $56 | $19.40 | +188.66% | 1 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $545 → $546 | $169.76 | +221.63% | 4 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $13 → $15 | $1.39 | +979.14% | 1 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $207 → $232 | $110.03 | +110.85% | 6 | Mar 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $770 → $880 | $1,248.62 | -29.52% | 3 | Oct 7, 2020 |
Agilent Technologies
Feb 26, 2026
Maintains: Buy
Price Target: $170 → $157
Current: $116.64
Upside: +34.60%
Exagen
Feb 24, 2026
Maintains: Buy
Price Target: $13 → $10
Current: $3.38
Upside: +195.86%
Guardant Health
Feb 20, 2026
Maintains: Buy
Price Target: $130 → $135
Current: $91.20
Upside: +48.03%
Bruker
Feb 13, 2026
Maintains: Hold
Price Target: $53 → $43
Current: $37.20
Upside: +15.59%
10x Genomics
Feb 13, 2026
Maintains: Hold
Price Target: $18 → $19
Current: $20.91
Upside: -9.13%
Revvity
Feb 3, 2026
Maintains: Buy
Price Target: $120 → $124
Current: $92.11
Upside: +34.62%
Thermo Fisher Scientific
Jan 30, 2026
Maintains: Buy
Price Target: $696 → $683
Current: $509.97
Upside: +33.93%
Illumina
Jan 7, 2026
Maintains: Hold
Price Target: $115 → $140
Current: $124.28
Upside: +12.65%
Danaher
Jan 7, 2026
Maintains: Buy
Price Target: $260 → $270
Current: $198.80
Upside: +35.81%
Avantor
Jan 7, 2026
Maintains: Hold
Price Target: $14 → $12
Current: $8.15
Upside: +47.24%
Nov 13, 2025
Maintains: Buy
Price Target: $5 → $7
Current: $3.38
Upside: +107.10%
Nov 5, 2025
Maintains: Hold
Price Target: $345 → $390
Current: $305.67
Upside: +27.59%
Nov 4, 2025
Maintains: Buy
Price Target: $74 → $90
Current: $103.71
Upside: -13.22%
Nov 4, 2025
Maintains: Hold
Price Target: $8 → $9
Current: $4.81
Upside: +87.11%
Sep 12, 2025
Maintains: Buy
Price Target: $10 → $12
Current: $8.92
Upside: +34.53%
Aug 6, 2025
Maintains: Buy
Price Target: $13 → $15
Current: $14.95
Upside: +0.33%
Jul 14, 2025
Initiates: Buy
Price Target: $32
Current: $19.00
Upside: +68.42%
May 1, 2025
Maintains: Buy
Price Target: $135 → $110
Current: $94.51
Upside: +16.39%
Mar 21, 2025
Maintains: Neutral
Price Target: $8 → $2.5
Current: $3.63
Upside: -31.13%
Feb 5, 2025
Reinstates: Buy
Price Target: $74
Current: $52.32
Upside: +41.44%
Nov 13, 2024
Maintains: Buy
Price Target: $155 → $175
Current: $205.22
Upside: -14.73%
Nov 7, 2024
Maintains: Buy
Price Target: $240 → $250
Current: $176.99
Upside: +41.25%
Jul 23, 2024
Maintains: Buy
Price Target: $48 → $51
Current: $50.45
Upside: +1.09%
May 13, 2024
Initiates: Buy
Price Target: $56
Current: $19.40
Upside: +188.66%
Dec 8, 2023
Maintains: Outperform
Price Target: $545 → $546
Current: $169.76
Upside: +221.63%
Mar 31, 2023
Upgrades: Outperform
Price Target: $13 → $15
Current: $1.39
Upside: +979.14%
Mar 1, 2021
Upgrades: Buy
Price Target: $207 → $232
Current: $110.03
Upside: +110.85%
Oct 7, 2020
Downgrades: Sell
Price Target: $770 → $880
Current: $1,248.62
Upside: -29.52%